Description

Durataz 1000 mg/125 mg Injection is a broad-spectrum antibiotic combination used for the treatment of moderate to severe bacterial infections. It contains Piperacillin, a penicillin-class antibiotic that kills bacteria by inhibiting cell wall synthesis, and Tazobactam, a beta-lactamase inhibitor that prevents bacterial enzymes from destroying Piperacillin.

Together, this combination is more effective against resistant bacteria and is commonly used in hospital and clinical settings for serious infections. It is administered by a healthcare professional as an intravenous (IV) or intramuscular (IM) injection.

Uses / Indications

Lower respiratory tract infections (pneumonia, bronchitis)
Urinary tract infections (complicated and uncomplicated)
Intra-abdominal infections (peritonitis, appendicitis)
Skin and soft tissue infections (cellulitis, wound infections)
Septicemia (blood infections)
Gynecological infections
Bone and joint infections
Hospital-acquired infections caused by resistant bacteria

How It Works (Mechanism of Action)

Piperacillin (1000 mg): Inhibits bacterial cell wall synthesis → causes bacterial cell death.
Tazobactam (125 mg): Inhibits beta-lactamase enzymes → protects Piperacillin from breakdown by resistant bacteria.
Combined Effect: Extends antibacterial spectrum and makes treatment more effective against difficult-to-treat infections.

Dosage & Administration

Administered by a doctor or nurse through IV infusion or IM injection.
Dosage depends on type and severity of infection, age, weight, and kidney function of the patient.
Usual adult dose: Every 6–8 hours (as prescribed).
Treatment duration varies from a few days to weeks, depending on the infection.

Side Effects

Common:

Diarrhea, nausea, vomiting
Injection site pain or swelling
Rash, itching
Headache, insomnia

Serious (rare):

Severe allergic reactions (swelling of face, lips, throat, difficulty breathing)
Clostridium difficile–associated diarrhea (severe diarrhea with blood/mucus)
Low blood cell counts (anemia, leukopenia, thrombocytopenia)
Electrolyte imbalance (low potassium levels)
Seizures (especially in patients with kidney impairment)

Precautions & Warnings

Not recommended in patients with a history of allergy to penicillin, cephalosporins, or beta-lactam antibiotics.
Caution in patients with kidney disease, liver disease, or seizure disorders.
Prolonged use may cause secondary infections (fungal or resistant bacteria).
Regular monitoring of kidney function, liver enzymes, and blood counts may be required during long-term therapy.
Use in pregnancy or breastfeeding should only be under medical advice.

Summary

Durataz 1000 mg/125 mg Injection is a powerful antibiotic containing Piperacillin (1000 mg) and Tazobactam (125 mg). It is widely used in hospitals for the treatment of severe infections caused by resistant bacteria. By combining Piperacillin with Tazobactam, it ensures enhanced antibacterial activity and prevents drug resistance. Administration should always be under the supervision of a healthcare professional.

Durataz 1000 mg/125 mg Injection